TARC
TARC (C-C motif chemokine ligand 17, also known as CCL17, ABCD-2 or SCYA17) is a secreted CC chemokine that attracts T lymphocytes, preferentially Th2 cells. It acts through CCR4 and contributes to inflammatory and immunological processes. Browse Assay Genie's current range of TARC research reagents below, or read on for the biology behind the target.
TARC is a chemokine with chemotactic activity for T lymphocytes, preferentially Th2 cells, but not for monocytes or granulocytes. It acts by binding to CCR4 on the T-cell surface, and the NCBI Gene summary also lists CCR8 as a receptor. Through these interactions it plays an important part in a wide range of inflammatory and immunological processes, including T cell development in the thymus and the trafficking and activation of mature T cells.
Beyond T cell biology, TARC mediates GM-CSF/CSF2-driven pain and inflammation. In the brain it is required to maintain the typical, highly branched morphology of hippocampal microglia under homeostatic conditions. It may also help microglial morphology and synaptic plasticity adapt to acute lipopolysaccharide (LPS)-induced neuroinflammation. In wound healing, it acts mainly by inducing fibroblast migration into the wound.
The CCL17 gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16, and the NCBI summary describes it as an antimicrobial gene. The CC cytokines are secreted proteins characterised by two adjacent cysteines, and TARC belongs to the intercrine beta (chemokine CC) family. Previous names include small inducible cytokine subfamily A (Cys-Cys), member 17, and the gene is listed by HGNC in the chemokine ligands group. Mouse and rat both carry a Ccl17 ortholog, which makes the TARC protein accessible to comparative studies of chemokine signalling.
TARC attracts Th2-skewed T lymphocytes through CCR4, making it relevant to studies of inflammatory and immunological processes.
The chemokine contributes to T cell development in the thymus and to trafficking and activation of mature T cells.
TARC helps maintain hippocampal microglial morphology and may shape responses to LPS-induced neuroinflammation and synaptic plasticity.
TARC induces fibroblast migration into wounds and mediates GM-CSF-driven pain and inflammation.
TARC is a secreted chemokine that attracts T lymphocytes, preferentially Th2 cells, but not monocytes or granulocytes. It binds CCR4 on the T-cell surface. It also supports microglial morphology in the hippocampus and promotes fibroblast migration during wound healing.
TARC is encoded by CCL17, and HGNC names it C-C motif chemokine ligand 17. Aliases and earlier symbols include ABCD-2 and SCYA17. Earlier names were small inducible cytokine subfamily A (Cys-Cys), member 17, and chemokine (C-C motif) ligand 17.
Yes. Mouse and rat each have a Ccl17 ortholog of the human gene. Human TARC belongs to the CC chemokine family, whose genes cluster on chromosome 16q. Check the datasheet of any product for its validated reactivity.
Other CC chemokine ligands involved in immune cell trafficking and inflammatory signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92583; product specifications from Assay Genie datasheets.